Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of......
If things go according to plan, the vaccine would be available in the market by the end of this year. IMAGE: Kindly note that this image has been posted for representational purposes only.......
The first nasal vaccine against COVID-19, developed by Bharat Biotech, has received regulator's nod for conducting phase 2 clinical trials, the Department of Biotechnology said on Friday. Phase 1......
A parliamentary panel meeting on the issue of vaccine development witnessed high drama on Wednesday as several Bharatiya Janata Party MPs walked out of it asserting that this is not the appropriate......
Efforts are being ramped up for massive production of vaccines and make them available in the shortest possible time, a top government official said on Wednesday, stressing that India currently has......